Benzinga | Aug 6, 2020 05:08PM EDT

Amphastar Pharmaceuticals Q2 EPS $0.16 Beats $0.14 Estimate, Sales $85.81M Miss $86.62M Estimate

Amphastar Pharmaceuticals (NASDAQ:AMPH) reported quarterly earnings of $0.16 per share which beat the analyst consensus estimate of $0.14 by 14.29 percent. This is a 100 percent increase over earnings of $0.08 per share from the same period last year. The company reported quarterly sales of $85.81 million which missed the analyst consensus estimate of $86.62 million by 0.94 percent. This is a 8.55 percent increase over sales of $79.05 million the same period last year.